Close Menu

NEW YORK (GenomeWeb) – Becton Dickinson reported today that its fiscal second quarter revenues decreased approximately 1 percent year over year.

On a comparable, currency-neutral basis, Q2 revenues increased more than 3 percent, BD said.

For the three months ended March 31, BD posted revenues of $4.20 billion compared to $4.22 billion in the year-ago quarter and below the analysts' average estimate of $4.24 billion.

BD's Medical segment revenues were up less than 1 percent to $2.18 billion from $2.17 billion a year ago. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.